FutureNeuro Header image
epiexchange

A community building event for epilepsy research

 Seven large EU-funded projects have joined forces – epiXchange 2018 brings together Europe’s best brains to pave the way for future epilepsy research. Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large…

FutureNeuro RGB

FutureNeuro and GreenLight Medicines partner to develop new cannabis-based treatments for epilepsy

Novel cannabinoids could provide new therapy options for patients with drug-resistant epilepsy   A new partnership between FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI and GreenLight Medicines, an indigenous Irish biopharmaceutical company has been formed to develop new cannabis-based treatments for drug resistant epilepsies, and in particular, childhood…

epiexchange

FutureNeuro Director joins forces with other large EU-funded projects to organise epiXchange 2018

Professor David Henshall, FutureNeuro Director and co-ordinator of EpimiRNA, has joined forces with six other large EU-funded projects  to organise epiXchange 2018, which brings together Europe’s best brains to pave the way for future epilepsy research. Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease…

FN Congenica combined

FutureNeuro and Congenica Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

Development of new software will improve treatment options for patients New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation…